Every 8-K that Cronos Group Inc. (CRON) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow CRON and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CRON filings page.
Cronos Group Inc. (symbol: CRON) is the issuer of record for a Form 8-K filing submitted to the SEC.
Cronos Group Inc. adopted an annual schedule for shareholder Say-on-Pay Votes on executive compensation. At the 2026 Annual Meeting of Shareholders held on June 18, 2026, investors indicated a preference for annual votes. The board has now decided to follow that preference until the next required Say-on-Frequency Vote.
Cronos Group Inc. reported a record second quarter for the period ended June 30, 2026, with net revenue of $53.0 million, up 58% year-over-year, and gross profit of $28.5 million, up 96%. Gross margin expanded to 54%, reflecting a mix shift toward Israel and other export markets that are not subject to excise taxes, along with higher sales volumes.
The company generated net income of $35.7 million, compared to a net loss of $38.5 million a year earlier, and Adjusted EBITDA of $13.1 million, up from $1.7 million. Revenue growth was broad-based, including Canada, a tenth consecutive record quarter in Israel under the PEACE NATURALS® brand, and strong demand in Germany and other markets. Cronos ended the quarter with $827.0 million in cash, short-term investments and interest-bearing deposits and had repurchased 12.3 million shares in the first half of 2026, reducing shares outstanding to about 370.7 million. The company is prepared to close its pending acquisition of CanAdelaar B.V. in the Netherlands, while also facing a new Israeli anti-dumping investigation that could affect medical cannabis imports into that market.
Cronos Group Inc. reported results from its 2026 Annual Meeting of Shareholders held on June 18, 2026. Shareholders elected seven directors, each receiving over 207 million votes in favor, with Jason Adler and Darren Broughton each receiving about 220.5 million votes for.
Shareholders approved, on an advisory basis, the compensation of the named executive officers with 219,776,593 votes for and 1,624,630 against. In a separate advisory vote on the frequency of future say-on-pay votes, the largest number of votes, 207,874,325, supported holding the vote every one year. Shareholders also approved the appointment of Davidson & Company LLP as independent auditor for fiscal 2026, with 268,504,336 votes for and 3,324,423 withheld.
Cronos Group Inc. reported strong first quarter 2026 results, with net revenue rising 40% year-over-year to $45.2 million and net income more than doubling to $15.7 million. Adjusted EBITDA improved to $5.1 million, up 122% from the prior-year period, helped by higher cannabis flower and extract sales in Canada, Israel and other international markets.
The company’s Spinach, PEACE NATURALS, LIT and Lord Jones brands all contributed to growth, including #1 vape share in Canada and continued leadership in Israeli medical cannabis. Cronos ended the quarter with $821.9 million in cash and cash equivalents and authorized a new share repurchase program of up to $50 million running through May 2027. The company also extended the outside date to close its pending acquisition of Dutch producer CanAdelaar B.V. to September 9, 2026 to allow more time for regulatory clearances.
Cronos Group Inc. reported strong growth for 2025 while staying roughly breakeven on the bottom line. Net revenue rose 25% to $146.6 million, with Q4 net revenue up 47% year-over-year to $44.5 million, driven by cannabis flower sales in Israel and other international markets plus higher Canadian flower and extract sales.
Full-year gross profit increased to $62.8 million, and gross margin expanded to 43%. Adjusted EBITDA swung to a positive $10.1 million from a loss of $34.9 million in 2024, reflecting higher adjusted gross profit and lower operating expenses. The company recorded a modest net loss of $2.9 million, compared with net income of $40.0 million a year earlier, mainly due to foreign currency transaction losses versus prior gains.
Cronos ended 2025 with an industry-leading liquidity position of $831.8 million in cash and cash equivalents plus short-term investments. It agreed to acquire Dutch producer CanAdelaar for upfront cash consideration of €57.5 million (approximately $67 million) plus an earnings-based earnout, gaining a leading supplier in the Netherlands’ legal adult-use cannabis experiment. The company highlighted strong brand momentum for Spinach®, SOURZ by Spinach®, PEACE NATURALS® and Lord Jones® across Canada and Israel, and appointed Jared Matthew Kenost as Principal Accounting Officer and Vice President, Controller.
Cronos Group Inc. furnished an 8-K announcing it issued a press release with financial results for its third quarter ended September 30, 2025.
The press release is attached as Exhibit 99.1. The Item 2.02 information, including Exhibit 99.1, is being furnished, not filed, and is not subject to Section 18 liability or automatically incorporated into other filings. Exhibit 104 provides the cover page Inline XBRL data.
Cronos Group Inc. announced the immediate termination for cause of Lloyd Wilson, who served as Vice President, Controller and Principal Accounting Officer. The company explicitly stated that Wilson's termination was not connected to Cronos Group's financial or operating results, internal controls, or any disagreements regarding the company's financial reporting practices.
On 7 Aug 2025 Cronos Group Inc. (NASDAQ: CRON) filed a Form 8-K disclosing two matters:
- Item 2.02 – Results of Operations: the company issued a press release (Exhibit 99.1) containing its Q2-2025 financial results for the period ended 30 Jun 2025. Specific revenue, earnings or guidance figures are not included in the 8-K body; investors must refer to the attached exhibit for details.
- Item 5.02 – Officer change: effective immediately after the forthcoming Form 10-Q, the Board appointed Lloyd Wilson (53), currently Vice President & Controller, as Principal Accounting Officer. Wilson brings 20+ years of GAAP and SEC-reporting experience, most recently as Corporate Controller at Vital Farms (Nov 2021–Jun 2025) and previously as an auditor at Grant Thornton and KPMG. He replaces James McGinness, who departs the company on the same date.
The filing notes no family relationships, related-party transactions or special arrangements tied to Wilson’s selection. Other sections are routine, and no forward-looking guidance was provided.